Researchers from Tel Aviv University and the Israel Institute for Biological Research in Ness Ziona have used the platform developed for COVID-19 vaccines to create the world’s first mRNA-based vaccine against a deadly, antibiotic-resistant bacterium.
COVID-19 vaccine technology adapted to develop first mRNA defense against antibiotic-resistant bacteria
